期刊
CELL STEM CELL
卷 2, 期 3, 页码 205-213出版社
CELL PRESS
DOI: 10.1016/j.stem.2008.02.005
关键词
-
资金
- NHLBI NIH HHS [R01 HL069957] Funding Source: Medline
- NIA NIH HHS [R43AG029705] Funding Source: Medline
- NIDCR NIH HHS [R37 DE0133033, R01DE013349] Funding Source: Medline
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069957] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013349] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON AGING [R43AG029705] Funding Source: NIH RePORTER
Many cell populations, derived from both adult tissues and embryonic stem cells, show promise for the treatment of a variety of diseases. Although the major effort in stem cell therapies in the past has been identifying potentially therapeutic cells, it is now clear that developing systems to deliver these cells and promote their efficient engraftment will provide an equally challenging task. More sophisticated pretransplantation manipulations and material carriers may dramatically improve the survival, engraftment, and fate control of transplanted stem cells and their ultimate clinical utility.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据